Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds

被引：0
作者：
Atatreh, Noor [1 ,2 ]
Mahgoub, Radwa E. [1 ,2 ]
Ghattas, Mohammad A. [1 ,2 ]
机构：
[1] Al Ain Univ, Coll Pharm, Abu Dhabi, U Arab Emirates
[2] Al Ain Univ, AAU Hlth & Biomed Res Ctr, Abu Dhabi, U Arab Emirates
来源：
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 2025年 / 40卷 / 01期
关键词：
Anti-viral; irreversible inhibition; covalent inhibitor; Covid-19; warheads reactivity; PEPTIDE ALDEHYDE INHIBITORS; COV M-PRO; 3C-LIKE PROTEASE; CRYSTAL-STRUCTURES; DESIGN; DISCOVERY; PROTEINASE; REVEALS; TARGET; SITE;
D O I：
10.1080/14756366.2025.2460045
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Peptidomimetic inhibitors mimic natural peptide substrates, employing electrophilic warheads to covalently interact with the catalytic Cys145 of Mpro. Examples include aldehydes, alpha-ketoamides, and aza-peptides, with discussions on their mechanisms of action, potency, and structural insights. Non-peptidomimetic inhibitors utilise diverse scaffolds and mechanisms, achieving covalent modification of Mpro.
引用
收藏
页数：26
相关论文
共 128 条
  • [51] Pyrazolidinone-based peptidomimetic SARS-CoV-2 Mpro inhibitors
    Jelisejevs, Daniels
    Bula, Anna Lina
    Kinena, Linda
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 96
  • [52] Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
    Jin, Zhenming
    Du, Xiaoyu
    Xu, Yechun
    Deng, Yongqiang
    Liu, Meiqin
    Zhao, Yao
    Zhang, Bing
    Li, Xiaofeng
    Zhang, Leike
    Peng, Chao
    Duan, Yinkai
    Yu, Jing
    Wang, Lin
    Yang, Kailin
    Liu, Fengjiang
    Jiang, Rendi
    Yang, Xinglou
    You, Tian
    Liu, Xiaoce
    Yang, Xiuna
    Bai, Fang
    Liu, Hong
    Liu, Xiang
    Guddat, Luke W.
    Xu, Wenqing
    Xiao, Gengfu
    Qin, Chengfeng
    Shi, Zhengli
    Jiang, Hualiang
    Rao, Zihe
    Yang, Haitao
    [J]. NATURE, 2020, 582 (7811) : 289 - +
  • [53] Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors
    Khatua, Kaustav
    Alugubelli, Yugendar R.
    Yang, Kai S.
    Vulupala, Veerabhadra R.
    Blankenship, Lauren R.
    Coleman, Demonta
    Atla, Sandeep
    Chaki, Sankar P.
    Geng, Zhi Zachary
    Xiao, Jing
    Chen, Peng-Hsun
    Cho, Chia-Chuan D.
    Sharma, Shivangi
    Vatansever, Erol C.
    Ma, Yuying
    Yu, Ge
    Neuman, Benjamin W.
    Xu, Shiqing
    Liu, Wenshe Ray
    [J]. ANTIVIRAL RESEARCH, 2024, 225
  • [54] The role of reversible and irreversible covalent chemistry in targeted protein degradation
    Kiely-Collins, Hannah
    Winter, Georg E.
    Bernardes, Goncalo J. L.
    [J]. CELL CHEMICAL BIOLOGY, 2021, 28 (07): : 952 - 968
  • [55] Broad-Spectrum Inhibitors against 3C-Like Proteases of Feline Coronaviruses and Feline Caliciviruses
    Kim, Yunjeong
    Shivanna, Vinay
    Narayanan, Sanjeev
    Prior, Allan M.
    Weerasekara, Sahani
    Hua, Duy H.
    Kankanamalage, Anushka C. Galasiti
    Groutas, William C.
    Chang, Kyeong-Ok
    [J]. JOURNAL OF VIROLOGY, 2015, 89 (09) : 4942 - 4950
  • [56] Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals
    Kneller, Daniel W.
    Galanie, Stephanie
    Phillips, Gwyndalyn
    O'Neill, Hugh M.
    Coates, Leighton
    Kovalevsky, Andrey
    [J]. STRUCTURE, 2020, 28 (12) : 1313 - +
  • [57] Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography
    Kneller, Daniel W.
    Phillips, Gwyndalyn
    O'Neill, Hugh M.
    Jedrzejczak, Robert
    Stols, Lucy
    Langan, Paul
    Joachimiak, Andrzej
    Coates, Leighton
    Kovalevsky, Andrey
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [58] 3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents
    Konno, Sho
    Kobayashi, Kiyotaka
    Senda, Miki
    Funai, Yuta
    Seki, Yuta
    Tamai, Ikumi
    Schaekel, Laura
    Sakata, Kyousuke
    Pillaiyar, Thanigaimalai
    Taguchi, Akihiro
    Taniguchi, Atsuhiko
    Guetschow, Michael
    Mueller, Christa E.
    Takeuchi, Koh
    Hirohama, Mikako
    Kawaguchi, Atsushi
    Kojima, Masaki
    Senda, Toshiya
    Shirasaka, Yoshiyuki
    Kamitani, Wataru
    Hayashi, Yoshio
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) : 2926 - 2939
  • [59] dIdentification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen
    Kuzikov, Maria
    Costanzi, Elisa
    Reinshagen, Jeanette
    Esposito, Francesca
    Vangeel, Laura
    Wolf, Markus
    Ellinger, Bernhard
    Claussen, Carsten
    Geisslinger, Gerd
    Corona, Angela
    Iaconis, Daniela
    Talarico, Carmine
    Manelfi, Candida
    Cannalire, Rolando
    Rossetti, Giulia
    Gossen, Jonas
    Albani, Simone
    Musiani, Francesco
    Herzog, Katja
    Ye, Yang
    Giabbai, Barbara
    Demitri, Nicola
    Jochmans, Dirk
    De Jonghe, Steven
    Rymenants, Jasper
    Summa, Vincenzo
    Tramontano, Enzo
    Beccari, Andrea R.
    Leyssen, Pieter
    Storici, Paola
    Neyts, Johan
    Gribbon, Philip
    Zaliani, Andrea
    [J]. ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2021, 4 (03) : 1096 - 1110
  • [60] Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332
    Li, Jian
    Lin, Cheng
    Zhou, Xuelan
    Zhong, Fanglin
    Zeng, Pei
    Yang, Yang
    Zhang, Yuting
    Yu, Bo
    Fan, Xiaona
    McCormick, Peter J.
    Fu, Rui
    Fu, Yang
    Jiang, Haihai
    Zhang, Jin
    [J]. JOURNAL OF VIROLOGY, 2022, 96 (08)
12345678910